Our Projects
Our Projects
SNUBH CPT Clinical Trials
-
61
Clinical Trials
-
40
SIT (Sponsor Initiated Trial)
-
21
IIT (Investigator Initiated Trial)
Project Board
| NO | 프로젝트 | 연도 | 타입 | 의뢰사 | 비고 |
|---|---|---|---|---|---|
| 25 | AST-001P_P101 | 2020 | [FIH] PK | (주)아스트로젠 | nan |
| 24 | DW_DWP14012005 | 2020 | DDI | ㈜대웅제약 | NCT04490434 |
| 23 | AVI-DES-CT001 | 2019 | [FIH] PK | (주)에빅스젠 | nan |
| 22 | DW_DWP16001103 | 2019 | PK/PD | ㈜대웅제약 | NCT04221399 |
| 21 | DDS19-030BE | 2019 | PK/PD (BE) | Phargentis SA | nan |
| 20 | GNC_PT1_2018001 | 2019 | [FIH] PK | ㈜제넨셀 | nan |
| 19 | A86_04BE1913P | 2019 | PK (복합제 Compartive PK) | ㈜종근당 | NCT04304547 |
| 18 | A86_02BE1902P | 2019 | PK (복합제 Compartive PK) | ㈜종근당 | NCT04272502 |
| 17 | CT-P17 | 2019 | PK (Biosimilar) | ㈜셀트리온 | NCT03970824 |
| 16 | DDS16-045BE | 2019 | - | 알보젠코리아㈜ | nan |
| 15 | DW_EGF102OP | 2019 | [FIH] PK | ㈜대웅바이오 | NCT05219461 |
| 14 | CKD-391 | 2018 | PK (복합제 Compartive PK) | ㈜종근당 | NCT04354987 |